SMU-L11
Product Specifications
Target
NF-κB, MAPK, TLR
Related Pathways
Immunology/Inflammation, NF-κB, MAPK
Bioactivity
SMU-L11 is a specific TLR7 agonist (EC50=0.024 μM) that recruits the MyD88 adaptor protein, activating downstream NF-κB and MAPK signaling pathways. In mouse models, SMU-L11 significantly enhances immune cell activation and boosts CD4+ T and CD8+ T cell proliferation, leading to direct tumor cell destruction and inhibition of tumor growth. This compound has applications in cancer research and potential in studying immune system disorders.
Molecular Formula
C19H24N4O
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-432589-LAC 200 µL
C030046E11Rik Lentiviral Activation Particles (m)
Sign In for Pricing
View Details